Download PDF
DO - Deutsche Zeitschrift für Osteopathie 2015; 13(03): 24-29
DOI: 10.1055/s-0035-1546019
praxis
Karl F. Haug Verlag in MVS Medizinverlage Stuttgart GmbH & Co. KG Stuttgart · New York

Entzündungsreaktionen aus Sicht der Osteopathie

Robert Sarzeaud
,
Nils Thon
,
Johannes Fetzer
Further Information

Publication History

Publication Date:
10 July 2015 (online)

Also available at
   Permissions and Reprints

Dieser Artikel scheint auf den ersten Blick wenig mit der Osteopathie zu tun zu haben, er behandelt jedoch ein ganz zentrales Thema unserer täglichen Arbeit: Wenn wir auf das Gewebe Druck oder Zug ausüben, haben wir häufig gar keine Vorstellung von all den Mechanismen, die unter unseren Händen ablaufen. Am Beispiel des Entzündungsprozesses wollen wir aufzeigen, welche Ebenen unsere Hände beeinflussen können.

 

  • Literatur

  • 1 Ingber DE. Tensegrity-based mechanosensing from macro to micro. Prog Biophys Mol Biol 2008; 97(2–3): 163-179
    CrossrefPubMedGoogle Scholar
  • 2 Engler AJ, Carag-Krieger C, Johnson CP, Raab M et al. Embryonic cardiomyocytes beat best on a matrix with heart-like elasticity: scar-like rigidity inhibits beating. J Cell Sci 2008; 121 (Pt 22) 3794-3802
    CrossrefGoogle Scholar
  • 3 Weaver VM, Gilbert P. Watch thy neighbor: cancer is a communal affair. J Cell Sci 2004; 117 (Pt 8) 1287-1290
    CrossrefGoogle Scholar
  • 4 Whitehead J, Vignjevic D, Fütterer C, Beaurepaire E et al. Mechanical factors activate beta-catenin-dependent oncogene expression in APC mouse colon. HFSP J 2008; 2 (5) 286-294
    CrossrefGoogle Scholar
  • 5 Farge E. Mechanotransduction in development. Curr Top Dev Biol 2011; 95: 243-265
    Google Scholar
  • 6 Desclaux M, Teigell M, Amar L, Vogel R et al. A novel and efficient gene transfer strategy reduces glial reactivity and improves neuronal survival and axonal growth in vitro. PLoS One 2009; 4 (7) e6227
    CrossrefGoogle Scholar
  • 7 Cochain C, Auvynet C, Poupel L, Vilar J et al. The chemokine decoy receptor D6 prevents excessive inflammation and adverse ventricular remodeling after myocardial infarction. Arterioscler Thromb Vasc Biol 2012; 32 (9) 2206-2213
    CrossrefGoogle Scholar
  • 8 Levental KR, Yu H, Kass L, Lakins JN et al. Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 2009; 139 (5) 891-906
    CrossrefPubMedGoogle Scholar
  • 9 Paszek MJ, Zahir N, Johnson KR, Lakins JN et al. Tensional homeostasis and the malignant phenotype. Cancer Cell 2005; 8 (3) 241-254
    CrossrefGoogle Scholar
  • 10 Yu H, Mouw JK, Weaver VM. Forcing form and function: biomechanical regulation of tumor evolution. Trends Cell Biol 2011; 21 (1) 47-56
    CrossrefGoogle Scholar
  • 11 Jackson JR, Seed MP, Kircher CH et al. The codependence of angiogenesis and chronic inflammation. FASEB J 1997; 11 (6) 457-465
    Google Scholar
  • 12 Toole BP, Wight TN, Tammi MI. Hyaluronan-cell interactions in cancer and vascular disease. J Biol Chem 2002; 277 (7) 4593-4596
    CrossrefGoogle Scholar
  • 13 Reed RK, Rubin K, Wiig H et al. Blockade of beta 1-integrins in skin causes edema through lowering of interstitial fluid pressure. Circ Res 1992; 71 (4) 978-983
    CrossrefGoogle Scholar
  • 14 De La Motte CA, Hascall VC, Calabro A et al. Mononuclear leukocytes preferentially bind via CD44 to hyaluronan on human intestinal mucosal smooth muscle cells after virus infection or treatment with poly(I.C). J Biol Chem 1999; 274 (43) 30747-30755
    CrossrefGoogle Scholar
  • 15 Flavell SJ, Hou TZ, Lax S, Filer AD et al. Fibroblasts as novel therapeutic targets in chronic inflammation. Br J Pharmacol 2008; 153
    Google Scholar
  • 16 Tolg C, Hamilton SR, Zalinska E, McCulloch L et al. A RHAMM mimetic peptide blocks hyaluronan signaling and reduces inflammation and fibrogenesis in excisional skin wounds. Am J Pathol 2012; 181 (4) 1250-1270
    CrossrefGoogle Scholar
  • 17 Hoffmann A, Hoing JL, Newman M, Simman R. Role of Hyaluronic Acid Treatment in the Prevention of Keloid Scarring. J Am Coll Clin Wound Spec 2013; 4 (2) 23-31
    Google Scholar
  • 18 Meyer LJ, Russell SB, Russell JD, Trupin JS et al. Reduced hyaluronan in keloid tissue and cultured keloid fibroblasts. J Invest Dermatol 2000; 114 (5) 953-959
    CrossrefGoogle Scholar
  • 19 Tolg C, Telmer P, Turley E. Specific sizes of hyaluronan oligosaccharides stimulate fibroblast migration and excisional wound repair. PLoS One 2014; 9 (2) e88479
    CrossrefGoogle Scholar
  • 20 Karousou E, DʼAngelo ML, Kouvidi K, Vigetti D et al. Collagen VI and hyaluronan: the common role in breast cancer. Biomed Res Int 2014; 2014: 606458
    Google Scholar
  • 21 Frey H, Schroeder N, Manon-Jensen T, Iozzo RV et al. Biological interplay between proteoglycans and their innate immune receptors in inflammation. FEBS J 2013; 280 (10) 2165-2179
    CrossrefGoogle Scholar
  • 22 Aya KL, Stern R. Hyaluronan in wound healing: Rediscovering a major player. Wound Repair Regen 2014; 22 (5) 579-593
    CrossrefPubMedGoogle Scholar
  • 23 Camenisch TD, McDonald JA. Hyaluronan: is bigger better?. Am J Respir Cell Mol Biol 2000; 23 (4) 431-433
    CrossrefGoogle Scholar
  • 24 Weigel PH, Hascall VC, Tammi M. Hyaluronan synthases. J Biol Chem 1997; 272 (22) 13997-14000
    CrossrefGoogle Scholar
  • 25 De la Motte CA, Hascall VC, Drazba J, Bandyopadhyay SK et al. Mononuclear leukocytes bind to specific hyaluronan structures on colon mucosal smooth muscle cells treated with polyinosinic acid : polycytidylic acid: inter-alpha-trypsin inhibitor is crucial to structure and function. Am J Pathol 2003; 163 (1) 121-133
    CrossrefGoogle Scholar
  • 26 Nusgens BV. Hyaluronic acid and extracellular matrix: a primitive molecule? [Article in French]. Ann Dermatol Venereol 2010; 137 Suppl 1: 3-8
    CrossrefGoogle Scholar
  • 27 Petrey AC, De la Motte CA. Hyaluronan, a crucial regulator of inflammation. Front Immunol 2014; 5: 101
    Google Scholar
  • 28 Langevin HM, Bouffard NA, Badger GJ, Iatridis JC et al. Dynamic fibroblast cytoskeletal response to subcutaneous tissue stretch ex vivo and in vivo. Am J Physiol Cell Physiol 2005; 288 (3) C747-C756
    Google Scholar
  • 29 Dodd JG, Good MM, Nguyen TL, Grigg AI et al. In vitro biophysical strain model for understanding mechanisms of osteopathic manipulative treatment. J Am Osteopath Assoc 2006; 106 (3) 157-166
    Google Scholar
  • 30 Teodorczyk-Injeyan JA, Injeyan HS, Ruegg R. Spinal manipulative therapy reduces inflammatory cytokines but not substance P production in normal subjects. J Manipulative Physiol Ther 2006; 29 (1) 14-21
    CrossrefGoogle Scholar
  • 31 Meltzer KR, Standley PR. Modeled repetitive motion strain and indirect osteopathic manipulative techniques in regulation of human fibroblast proliferation and interleukin secretion. J Am Osteopath Assoc 2007; 107 (12) 527-536
    Google Scholar
  • 32 Teodorczyk-Injeyan JA, Injeyan HS, McGregor M, Harris GM et al. Enhancement of in vitro interleukin-2 production in normal subjects following a single spinal manipulative treatment. Chiropr Osteopat 2008; 16: 5 DOI: 10.1186/1746-1340-16-5.
    CrossrefGoogle Scholar
  • 33 www.google.fr Evanko Extracellular matrix and the manipulation of cells and tissues. Yearbook.
    Google Scholar
  • 34 Roy RA, Boucher JP, Comtois AS. Inflammatory response following a short-term course of chiropractic treatment in subjects with and without chronic low back pain. J Chiropr Med 2010; 9 (3) 107-114
    CrossrefGoogle Scholar
  • 35 Teodorczyk-Injeyan JA, McGregor M, Ruegg R, Injeyan HS. Interleukin 2-regulated in vitro antibody production following a single spinal manipulative treatment in normal subjects. Chiropr Osteopat 2010; 18: 26
    CrossrefGoogle Scholar
  • 36 Stecco C, Stern R, Porzionato A, Macchi V et al. Hyaluronan within fascia in the etiology of myofascial pain. Surg Radiol Anat 2011; 33 (10) 891-896
    CrossrefGoogle Scholar
  • 37 Hoheisel U, Taguchi T, Treede RD, Mense S. Nociceptive input from the rat thoracolumbar fascia to lumbar dorsal horn neurones. Eur J Pain 2011; 15 (8) 810-815
    CrossrefGoogle Scholar
  • 38 Langevin HM, Fox JR, Koptiuch C, Badger GJ et al. Reduced thoracolumbar fascia shear strain in human chronic low back pain. BMC Musculoskelet Disord 2011; 12: 203
    CrossrefGoogle Scholar
  • 39 Swanson RL. Biotensegrity: a unifying theory of biological architecture with applications to osteopathic practice, education, and research–a review and analysis. J Am Osteopath Assoc 2013; 113 (1) 34-52
    CrossrefGoogle Scholar
  • 40 Tozzi P. Selected fascial aspects of osteopathic practice. J Bodyw Mov Ther 2012; 16 (4) 503-519
    CrossrefGoogle Scholar
  • 41 Roman M, Chaudhry H, Bukiet B, Stecco A et al. Mathematical analysis of the flow of hyaluronic acid around fascia during manual therapy motions. J Am Osteopath Assoc 2013; 113 (8) 600-610
    CrossrefGoogle Scholar
  • 42 Hascall VC, Majors AK, De La Motte CA, Evanko SP et al. Intracellular hyaluronan: a new frontier for inflammation?. Biochim Biophys Acta 2004; 1673 (1–2) 3-12
    CrossrefGoogle Scholar
  • 43 Ruppert SM, Hawn TR, Arrigoni A, Wight TN et al. Tissue integrity signals communicated by high-molecular weight hyaluronan and the resolution of inflammation. Immunol Res 2014; 58 (2–3) 186-192
    CrossrefGoogle Scholar
  • 44 Schleip R, Klingler W, Lehmann-Horn F. Active fascial contractility: Fascia may be able to contract in a smooth muscle-like manner and thereby influence musculoskeletal dynamics. Med Hypotheses 2005; 65 (2) 273-277
    CrossrefGoogle Scholar